Search
for
Sort by
Research 811–840 of 874
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Ophthalmologic Comorbidities in Alopecia Areata
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience
- Real-world evidence in alopecia areata treatment: A narrative review
- Quality of life in patients with scarring and non‐scarring alopecia: An exploratory cross‐sectional study
- The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Comorbidities in primary cicatricial alopecia: a systematic review and meta-analysis
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Enhancing hair regrowth in Alopecia areata: the power duo of CO2 fractional laser and Bimatoprost
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Latanoprost
- Medical Remedies for Alopecia
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia
- Identification and characterization of alopecia areata subgroups regarding quality of life impairment based on demographic, clinical, psychological, and social factors
- An Overview of Commonly Used Natural Alternatives for the Treatment of Androgenetic Alopecia, with Special Emphasis on Rosemary Oil
- Permanent Makeup Removal Severe Complication—Case Report and Proposal of the Protocol for Its Management
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Immune niches for hair follicle development and homeostasis